A study confirmed that BHB acts through the surface receptor Hcar2 and induces the transcriptional regulator Hopx to change gene expression and inhibit CRC cell proliferation (Dmitrieva-Posocco et al. 2022). The gene discussed is HCAR2; the disease is colorectal carcinoma.